Identification of a series of potent telomerase inhibitors using a time- resolved fluorescence-based assay

Drug Development Research

Volumn 43, Issue 2, 1998, Pages 109-116

  Bare, Lance A ^a   Trinh, Lan ^a   Wu, Shung ^a   Devlin, James J ^a  

^a BAYER AG   (Germany)

Author keywords

Fluorescence screening assay; Telomerase

Indexed keywords

CELL EXTRACT; ENZYME INHIBITOR; ISOTHIAZOLONE; TELOMERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FLUORESCENCE; FLUOROMETRY; MOUSE; NONHUMAN; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; STRUCTURE ANALYSIS; TELOMERE;

EID: 0031866861     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199802)43:2<109::AID-DDR4>3.0.CO;2-O     Document Type: Article

References (26)

1. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harvey CB (1992): Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89:10114-10118.
2. Collier PJ, Ramsey AJ, Austin P, Gilbert P (1990): Chemical reactivity of some isothiazolone biocides. J Appl Bacteriol 69:578-584.
3. Counter CM, Avillion AA, LeFeure CE, Stewart NG, Greider CW, Harley CB, Bacchetti S (1992): Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1992.
4. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S (1994a): Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68:3410-3414.
5. Counter CM, Hirte HW, Bacchetti S, Harley CB (1994b): Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91:2900-2904.
6. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S (1995): Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85:2315-2320.
7. Dahlén P, Liukkonen L, Kwiatkowski M, Hurskainen P, Iitiä A, Sütari H, Ylikoski J, Mukkala V, Lövgren (1994): Europium-labeled oligonucleotide hybridization probes: Preparation and properties. Bioconjug Chem 5:268-272.
8. Devlin JJ, Liang A, Trinh L, Polokoff MA, Senator D, Zheng W, Kondracki J, Kretschmer PJ, Morser J, Lipson SE, Spann R, Loughlin JA, Dunn KV, Morrissey MM (1996): High capacity screening of pooled compounds: Identification of the active compound without re-assay of the pool members. Drug Dev Res 37:80-85.
9. Devos R, Guisez Y, Plaetinck G, Cornelis S, Tavernier J, Van Der Heyden J, Folley LH, Scheffler JE (1994): Covalent modification of the interleukin-5 receptor by isothiazolones leads to inhibition of the binding of interleukin-5. Eur J Biochem 225:635-640.
10. Greider CW, Blackburn EH (1996): Telomeres, telomerase and cancer. Sci Am 274:92-97.
11. Hemmilä I, Dakubu S, Mukkala VM, Sütari H, Lövgren T (1984): Europium as a label in time-resolved immunometric assays. Anal Biochem 137:335-343.
12. Holt SE, Shay JW, Wright WE (1996): Refining the telomere-telomerase hypothesis of aging and cancer. Nat Biotechnol 14:836-839.
13. Iitiä A, Dahlén P, Nunn M, Mukkala V, Sütari H (1992): Detection of amplified HTLV-I/-II viral sequences using time-resolved fluorometty. Anal Biochem 202:76-81.
14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West NM, Ho LC, Coviello CM, Wright WE, Weinrich SL, Shay JW (1994): Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
15. Loo JA, Holler TP, Sanchez J, Cogliotti R, Maloney L, Reily MD (1996): Biophysical characterization of zinc ejection from FHV nucleocapsid protein by anti-I-HV 2,2′-dithiobis[benzamides] and benzisothiazolones. Med Chem 39:4313-4320.
16. Parkinson EK (1996): Do telomerase antagonists represent a novel anticancer strategy? Br J Cancer 73:1-4.
17. Rice WG, Supko JG, Malspeis L, Buckheit RW Jr, Clanton D, Bu M, Graham L, Schaeffer CA, Turpin JA, Domagala J, Gogliotti R, Bader JP, Halliday SM, Coren L, Sowder RC II, Arthur LO, Henderson LE (1995): Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270:1194-1197.
18. Savoysky E, Akamatsu K, Tsuchiya M, Yamazaki T (1996): Detection of telomerase activity by combination of TRAP method and scintillation proximity assay (SPA). Nucleic Acids Res 24:1175-1176.
19. Schwartz HS, Juliao SF, Sciadini ME Miller LK, Butler MG (1995): Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer 75:1094-1099.
20. Shay JW, Werbin H, Wright WE (1996): Telomeres and telomerase in human leukemias. Leukemia 10:1255-1261.
21. Strahl C, Blackburn E (1996): Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 16:53-65.
22. Wright SW, Petraitis JJ, Abelman MM, Batt DG, Bostrom LL, Corbett RL, Decicco CP, Di Meo SV, Freimark B, Giannaras JV, Green AM, Jetter JW, Nelson DJ, Orwat MJ, Pinto DJ, Pratta MA, Sherk SR, William JM, Magolda RL, Amer EC (1994): Heteroaryl-fused 2-phenylisothiazolone inhibitors of cartilage breakdown. J Med Chem 37:3071-3078.
23. Wright SW, Petraitis JJ, Batt DG, Corbett RL, Di Meo SV, Freimark B, Giannaras JV, Orwat MJ, Pinto DJ, Pratta MA, Sherk SR, Stampfli HE Williams JM, Magolda RL, Amer EC (1995): Metabolism resistant isothiazolone inhibitors of cartilage breakdown. Bioorg Med Chem 3:227-234.
24. Wright WE, Shay JW (1995): Time, telomeres and tumours: Is cellular senescence more than an anticancer mechanism. Trends Cell Bio 5:293-297.
25. Wright WE, Shay IW, Piatyszek MA (1995): Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23:3794-3795.
26. Wright WE, Brasiskyte D, Piatyszek NM, Shay JW (1996): Experimental elongation of telomeres extends the lifespan of immortal × normal cell hybrids. EMBO J 15:1734-1741.